allegedly made multiple illegal trades in Ariad stock on the basis of non-public information he learned from her. Maureen Curran, a former Ariad executive, sold Ariad stock in December 2012, after she had attended meetings with the FDA …
High-flying biotech Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) was called out for its rapid drug price raises today by Senator Bernie Sanders, and its stock quickly crashed as a result. Since the beginning of the year, the company …
Senator Bernie Sanders just called out Ariad Pharmaceuticals over the price of its leukemia drug, and the …
The big news in the biotech sector this week is the acquisition agreement under which Japanese firm Takeda will be acquiring cancer-focused ARIAD ARIA for a whopping $5.2 billion. Several other licensing deals and agreements were …
New York, NY - (ACCESSWIRE) - 11/25/2013 - Growing Stock Report initiates its NASDAQ Active Stock Watch List adding Ariad Pharmaceuticals Inc. (NASDAQ:ARIA - News), Sirius XM Holdings Inc. (NASDAQ:SIRI - News), Dynavax …
StockHotTips.com Hot Stock News & Alerts! StockHotTips.com Stock Watch! ***** Power3 Medical Products, Inc. (OTCBB: PWRM) has announced that, in collaboration with Lourdes R. Bosquez, MD, it has unexpectedly discovered ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) announced today that it is offering to sell 16,000,000 shares of its common stock in an underwritten public offering. Jefferies & Company, Inc. and …
Ariad Pharmaceuticals.Inc ARIA was a big mover last session, as the company saw its shares rise by over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses …
While the description of his keynote focuses on the power of technology and Intel's latest advances, Krzanich is also expected to address two key concerns that …